Emotion and Interoception Processing in ALS

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to learn about the emotional perception in people with ALS disease compared to people with other neuromuscular disease and healthy controls. The main questions it aims to answer are: * How people with ALS judge happy and angry faces and what their insight into these judgements are like * How their autonomic responses differ from the other two test group Participants will asked to judge if a face presents a happy emotion or angry emotion. Researchers will compare the ALS group responses with neuromuscular diseases group and healthy control group responses to see if the ALS group judge more happy faces than angry.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• ALS patients, ambulant and hospitalized

‣ Able to give informed consent

⁃ Diagnosed with ALS or probable ALS according to the existing revision of the El Escorial Criteria 21,22.

• Patients with a peripheral neuromuscular disease, ambulant and hospitalized

‣ Able to give informed consent

⁃ Diagnosed with a peripheral neuromuscular disease, that does not affect CNS, including but not limited to Myasthenia Gravis and polyneuropathy

• Healthy controls

‣ Able to give informed consent

⁃ Age and gender matched to ALS patients

Locations
Other Locations
Denmark
Aalborg University Hospital
NOT_YET_RECRUITING
Aalborg
Aarhus University Hospital
RECRUITING
Aarhus
Contact Information
Primary
Mia B Heintzelmann, Cand.med
minielse@rm.dk
78454255
Backup
Camilla Hakala, Bach.psych
caha@cfin.au.dk
26332857
Time Frame
Start Date: 2023-12-15
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 180
Treatments
Amyotrophic Lateral Sclerosis (ALS)
People diagnosed or suspected of having the neurodegenerative disease Amyotrophic Lateral Sclerosis (ALS)
Neuromuscular
People diagnosed with a neuromuscular disease other than ALS
Control
Healthy people
Sponsors
Leads: University of Aarhus
Collaborators: Aalborg University Hospital, Aarhus University Hospital

This content was sourced from clinicaltrials.gov